Finally, in accordance with clinical evidence, we detected a preponderance of CD4 CAR-T cells in the bone marrow of mice who achieved tumor control (figure 6F), supporting their role in the maintenance of long-term antitumor activity. The gene discussed is CD4; the disease is neoplasm.